Multimodal, Technology-Assisted Intervention for the Management of Menopause After Cancer Improves Cancer-Related Quality of Life-Results From the Menopause After Cancer (Mac) Study
Source : https://www.mdpi.com/2072-6694/16/6/1127
Background: Vasomotor symptoms (VMSs) associated with menopause represent a significant challenge for many patients after cancer treatment, particularly if conventional menopausal hormone therapy (MHT) is contraindicated.
At least 50% reductions were noticed in the frequency of vasomotor symptoms as well as the degree of bother/interference of vasomotor symptoms at 6 months.
Share
The Association Between Hormone Replacement Therapy and Gastroparesis in Post-Menopausal Women: a Worldwide Database Analysis
Source : https://www.mdpi.com/2075-4426/14/3/275
Female sex hormones have been hypothesized to influence the higher prevalence of gastroparesis in females. This study investigated the effects of hormone replacement therapy (HRT) on gastroparesis and its related...
Hormone replacement therapy was associated with increased GI symptoms, including early satiety, domperidone use, and undergoing gastric emptying studies.
Share
Association Between Neighborhood Poverty and Ovarian Reserve: the Ovarian Aging Study
lerian hormone (AMH) and antral follicle count (AFC). Specifically, the interaction of age-x-neighborhood poverty was assessed cross-sectionally to determine whether AMH and AFC declines across women may be greater in...
Across women, greater aggregate exposure to neighborhood poverty in adulthood was related to lower ovarian reserve, indexed by antimüllerian hormone.
Share
Association Between Estrogen Replacement Therapy and Heart Failure in Postmenopausal Women: a Systematic Review and Meta-Analysis
Source : https://pubmed.ncbi.nlm.nih.gov/38382766/
This systematic review demonstrated that estrogen replacement therapy did not significantly change the risk of first hospitalized heart failure and admission to the hospital for heart failure in postmenopausal women.
Estrogen replacement therapy did not significantly change the risk of first hospital stay for heart failure and admission to the hospital for heart failure in postmenopausal women.
Share
Systematic Review of Neurokinin-3 Receptor Antagonists for the Management of Vasomotor Symptoms of Menopause
Source : https://pubmed.ncbi.nlm.nih.gov/38471077/
Because of the high-quality evidence supporting the efficacy of fezolinetant and elinzanetant, these agents may be an effective option with mild adverse events for women seeking nonhormone treatment of VMS.
Because of the high-quality evidence supporting the efficacy of fezolinetant and elinzanetant, these agents may be an effective option with mild adverse events for women seeking nonhormone treatment of vasomotor symptoms.
Share